Evaluation of an adapted relative growth method by MALDI-TOF MS for rapid determination of the susceptibility of Escherichia coli to levofloxacin
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.01035-26 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Yulong Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated Dazu's Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Escherichia coli, Levofloxacin, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Anti-Bacterial Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dazu District Major Joint Science and Health Project, Science and Technology Research Project of Chongqing Municipal Education Commission, Medical Image Intelligent Analysis and Application Innovation Team of Medical University China.
Abstract (Originalsprache)
Antimicrobial resistance (AMR) poses a critical global health threat. Conventional antimicrobial susceptibility testing (AST) requires 12–24 h, delaying targeted treatment. Although rapid AST approaches exist, their reliance on static measurements and single-colony analysis limits diagnostic accuracy by overlooking intrasample heterogeneity, which can produce misleading results when resistant subpopulations are present. Here, we present a novel analytical framework that integrates dynamic MALDI-TOF MS spectral analysis, the robust dynamic relative growth (RBD-RG) algorithm, and machine learning. This framework decodes the mass spectral evolution of Escherichia coli exposed to levofloxacin, enabling the rapid determination of levofloxacin susceptibility. AI MedLab MS was developed and validated using 60 clinical E. coli isolates, achieving robust classification performance across resistance phenotypes. Prospective validation with 50 independent isolates confirmed clinical utility: AI MedLab MS delivered AST results within 2 h, with an overall accuracy of 84.0% and a precision of 95.8% for resistant isolates. By shifting the analytical paradigm from single-timepoint detection to dynamic trajectory modeling, this study demonstrates a precise and interpretable methodology for rapid AST. The platform addresses key limitations of conventional methods by analyzing the overall bacterial population rather than individual colonies, thereby improving classification accuracy for complex resistance phenotypes, and has the potential to provide actionable clinical decision-making within a 2-h window. IMPORTANCE Rapid determination of antimicrobial susceptibility is critical for the management of severe bacterial infections, yet conventional culture-based assays require up to 24 h. While emerging rapid diagnostic tools offer shorter turnaround times, their accuracy is frequently limited by a reliance on static phenotypic endpoint measurements. Here, we report AI MedLab MS, a machine-learning-enabled diagnostic platform that captures the real-time, dynamic response profiles of Escherichia coli exposed to levofloxacin. By longitudinally tracking these continuous phenotypic transitions, our method differentiates drug-resistant strains within 2 h. This rapid profiling capability may provide actionable diagnostic insights to guide targeted therapy, with the potential to optimize clinical decision-making and support antimicrobial stewardship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Affiliated Dazu's Hospital of Chongqing Medical University, Chongqing, China.
- College of Artificial Intelligence Medicine, Chongqing Medical University, Chongqing, China.
Förderung
- Dazu District Major Joint Science and Health Project
- Science and Technology Research Project of Chongqing Municipal Education Commission
- Medical Image Intelligent Analysis and Application Innovation Team of Medical University China
Zitieren
APA
Liu, Y., Xie, N., Hu, W., Zeng, X., Sun, S., Pan, L., Chen, H., Peng, X., Yang, C., Han, B., & Li, J. (2026). Evaluation of an adapted relative growth method by MALDI-TOF MS for rapid determination of the susceptibility of Escherichia coli to levofloxacin. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01035-26
Vancouver
Liu Y, Xie N, Hu W, Zeng X, Sun S, Pan L, et al. Evaluation of an adapted relative growth method by MALDI-TOF MS for rapid determination of the susceptibility of Escherichia coli to levofloxacin. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01035-26
BibTeX
@article{Liu2026,
author = {Liu, Yulong and Xie, Niqi and Hu, Weiwei and Zeng, Xiaoqin and Sun, Siying and Pan, Lijuan and Chen, Hongyou and Peng, Xuelian and Yang, Chunyan and Han, Baoru and Li, Jin},
title = {Evaluation of an adapted relative growth method by MALDI-TOF MS for rapid determination of the susceptibility of Escherichia coli to levofloxacin},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.01035-26}
}
EUVIMED